US Patent 7863045 Isolation of skeletal precursor cells
Patent 7863045 was granted and assigned to Tigenix on January, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+277 characters)
Article
Patent abstract
Cartilage-derived morphogenetic protein CDMP-1 or a transforming growth factor β having at least 80% homology with CDMP-1, or a factor co-expressed and/or co-detectable therewith, is used as a marker of skeletal precursor cells from any part of a mammalian body.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Cosimo De Bari0
Francesco Dell'Accio0
Frank Luyten0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07863045 Isolation of skeletal precursor cells US Patent 7863045 Isolation of skeletal precursor cells
Infobox
Patent Number
078630450
Patent Number
78630450
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
078630450
Date of Patent
January 4, 2011
0Patent Application Number
121762560
Date Filed
July 18, 2008
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07863045 Isolation of skeletal precursor cells
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07863045
Date of patent
January 4, 2011
Patent application number
12176256
Date Filed
July 18, 2008
Patent primary examiner
Find more entities like US Patent 7863045 Isolation of skeletal precursor cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.